These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 23252936)
1. Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. Zhang L; Fourches D; Sedykh A; Zhu H; Golbraikh A; Ekins S; Clark J; Connelly MC; Sigal M; Hodges D; Guiguemde A; Guy RK; Tropsha A J Chem Inf Model; 2013 Feb; 53(2):475-92. PubMed ID: 23252936 [TBL] [Abstract][Full Text] [Related]
2. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304 [TBL] [Abstract][Full Text] [Related]
3. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum. Kumari M; Chandra S; Tiwari N; Subbarao N BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744 [TBL] [Abstract][Full Text] [Related]
4. Bayesian models trained with HTS data for predicting β-haematin inhibition and in vitro antimalarial activity. Wicht KJ; Combrinck JM; Smith PJ; Egan TJ Bioorg Med Chem; 2015 Aug; 23(16):5210-7. PubMed ID: 25573118 [TBL] [Abstract][Full Text] [Related]
5. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum. Aher RB; Roy K Comb Chem High Throughput Screen; 2014; 17(5):396-406. PubMed ID: 24372050 [TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR studies on Plasmodium falciparam proteins: a mini-review. Divakar S; Hariharan S Comb Chem High Throughput Screen; 2015; 18(2):188-98. PubMed ID: 25543683 [TBL] [Abstract][Full Text] [Related]
7. QSAR-Based Virtual Screening of Natural Products Database for Identification of Potent Antimalarial Hits. Ferreira LT; Borba JVB; Moreira-Filho JT; Rimoldi A; Andrade CH; Costa FTM Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808643 [TBL] [Abstract][Full Text] [Related]
8. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity. Levatić J; Pavić K; Perković I; Uzelac L; Ester K; Kralj M; Kaiser M; Rottmann M; Supek F; Zorc B Eur J Med Chem; 2018 Feb; 146():651-667. PubMed ID: 29407988 [TBL] [Abstract][Full Text] [Related]
9. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents. Sharma R; Patil S; Maurya P SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770 [TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR Modeling and Synthesis of New Fusidic Acid Derivatives as Antiplasmodial Agents. Kaur G; Pavadai E; Wittlin S; Chibale K J Chem Inf Model; 2018 Aug; 58(8):1553-1560. PubMed ID: 30040885 [TBL] [Abstract][Full Text] [Related]
11. The current status of antimalarial drug research with special reference to application of QSAR models. Ojha PK; Roy K Comb Chem High Throughput Screen; 2015; 18(2):91-128. PubMed ID: 25543681 [TBL] [Abstract][Full Text] [Related]
12. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery. Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851 [TBL] [Abstract][Full Text] [Related]
13. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203 [TBL] [Abstract][Full Text] [Related]
14. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box. Tiwari NK; Reynolds PJ; Calderón AI Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496 [TBL] [Abstract][Full Text] [Related]
15. In Silico Mining for Antimalarial Structure-Activity Knowledge and Discovery of Novel Antimalarial Curcuminoids. Viira B; Gendron T; Lanfranchi DA; Cojean S; Horvath D; Marcou G; Varnek A; Maes L; Maran U; Loiseau PM; Davioud-Charvet E Molecules; 2016 Jun; 21(7):. PubMed ID: 27367660 [TBL] [Abstract][Full Text] [Related]
16. QSAR and pharmacophore modeling of natural and synthetic antimalarial prodiginines. Singh B; Vishwakarma RA; Bharate SB Curr Comput Aided Drug Des; 2013 Sep; 9(3):350-9. PubMed ID: 24010933 [TBL] [Abstract][Full Text] [Related]
17. New horizons in antimalarial drug discovery in the last decade by chemoinformatic approaches. Ambre PK; Wavhale RD; Coutinho EC Comb Chem High Throughput Screen; 2015; 18(2):129-50. PubMed ID: 25543682 [TBL] [Abstract][Full Text] [Related]
18. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592 [TBL] [Abstract][Full Text] [Related]
19. Deep Learning-driven research for drug discovery: Tackling Malaria. Neves BJ; Braga RC; Alves VM; Lima MNN; Cassiano GC; Muratov EN; Costa FTM; Andrade CH PLoS Comput Biol; 2020 Feb; 16(2):e1007025. PubMed ID: 32069285 [TBL] [Abstract][Full Text] [Related]
20. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models. Aher RB; Roy K Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]